Pfizer's stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in PFE?

Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...

With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.

In 2024, Pfizer generated free cash flow of $9.8 billion, which was more than the $9.5 billion it paid out in dividends. 3. The company looks to still be in acquisition mode Pfizer previously told ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.

The Bluebird acquisition, which still needs the customary ... Bluebird shares will no longer be publicly traded. Pfizer’s Gene Therapy Pullback Continues With Termination of Beqvez Bluebird ...